About the Authors
- Ekkehard Schütz
-
Affiliation Chronix Biomedical, Göttingen, Germany
- Anna Fischer
-
Affiliation Department of Clinical Pharmacology, University Medical Center Göttingen, Göttingen, Germany
- Julia Beck
-
Affiliation Chronix Biomedical, Göttingen, Germany
- Markus Harden
-
Affiliation Department of Medical Statistics, University Medical Center Göttingen, Göttingen, Germany
- Martina Koch
-
Affiliation Department of Hepatobiliary Surgery and Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
- Tilo Wuensch
-
Affiliation Department of Surgery, Charité–Universitätsmedizin Berlin, Berlin, Germany
- Martin Stockmann
-
Affiliation Department of Surgery, Charité–Universitätsmedizin Berlin, Berlin, Germany
- Björn Nashan
-
Affiliation Department of Hepatobiliary Surgery and Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
- Otto Kollmar
-
Affiliation Department of General, Visceral and Pediatric Surgery, University Medical Center Göttingen, Göttingen, Germany
- Johannes Matthaei
-
Affiliation Department of Clinical Pharmacology, University Medical Center Göttingen, Göttingen, Germany
- Philipp Kanzow
-
Affiliation Department of Clinical Pharmacology, University Medical Center Göttingen, Göttingen, Germany
- Philip D. Walson
-
Affiliation Department of Clinical Pharmacology, University Medical Center Göttingen, Göttingen, Germany
- Jürgen Brockmöller
-
Affiliation Department of Clinical Pharmacology, University Medical Center Göttingen, Göttingen, Germany
- Michael Oellerich
-
* E-mail: michael.oellerich@med.uni-goettingen.de
Affiliation Department of Clinical Pharmacology, University Medical Center Göttingen, Göttingen, Germany
Competing Interests
I have read the journal's policy and the authors of this manuscript have the following competing interests: ES and JBe are employees of, and own stock and intellectual property rights at Chronix Biomedical, which provided parts of the reagents. MO acts as consultant and advisor to Chronix Biomedical. MK has received research grants from, and honoraria for speaking at Novartis and Teva. PDW was previously been a paid consultant to Chronix Biomedical. MH has served two paid internships in 2013 and 2014 at the Novartis Pharma AG. MH's position at the university was partly funded by the research project the analyses are based on (Federal Ministry of Education and Research (BMBF): "Personalized Immunosuppression after Liver Transplantation: an observational study on the utility and therapeutic ranges of innovative biomarkers"). MH has also received grants from the Federal Ministry of Education and Research for other research projects.
Author Contributions
Conceptualization: ES MO MK TW MS BN OK JM PK JBr. Data curation: MO AF PK. Formal analysis: ES MO JBe AF MH MK TW MS BN OK PK PDW. Investigation: ES MO JBe AF MK TW MS BN OK PK PDW JBr. Methodology: ES MO JBe. Software: MH. Validation: ES MO JBe AF MH PK PDW. Writing – original draft: ES MO PDW. Writing – review & editing: ES AF JBe MH MK TW MS BN OK JM PK PDW JBr MO.